May 21, 2013

Today’s issue is brought to you by Drug Benefit News, biweekly news, proven cost management strategies and unique data for health plans, PBMs, pharma companies and employers.

Big-Time Acquisitions for Two PBMs Lead to Major Pay Jumps for Top Execs
Reprinted from Drug Benefit News

Coinciding with big-dollar transactions made by two of the three publicly traded PBMs, top executives’ pay continued to rise at double-digit rates in 2012, in large part due to increases in incentive rewards, according to AIS’s review of company proxy statements filed with the Securities and Exchange Commission .... Read Full Story

“If carriers offer early renewals to healthier groups of enrollees — or if healthier consumers opt for early renewal while sicker consumers do not — this could result in adverse selection against the rest of the market, including the exchanges. This is of particular concern because one of the consumer protections that goes into effect in 2014, the requirement that insurers maintain a single risk pool when developing premiums, would not apply to early renewals.”

— Christine Monahan, a senior analyst at Georgetown University’s Health Policy Institute, told AIS’s Health Reform Week.

Click here to read the AIS's HEALTH REFORM WEEK article in which this quote appeared. (Free for HRW subscribers; $17 for non-subscribers).

Today's Datapoint

11 ... different private health insurance exchanges now offer Aetna products, CEO Mark Bertolini said in a recent quarterly earnings call.

Click here to read the HEALTH PLAN WEEK article in which this datapoint appeared. (Free for HPW subscribers; $17 for non-subscribers).

Reform barely impacts healthcare costs, use in Massachusetts

Healthcare reform in Massachusetts, which served as the model for the federal law, didn't lead to a significant increase in healthcare utilization, length of stay or costs, according to new research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013 ... Read more

• Congressional Record
• Federal Register

Achillion Pharmaceuticals, Inc. named David Apelian, M.D., executive vice president and chief medical officer (CMO). Apelian was senior vice president of research and development and CMO at GlobeImmune....Humana Inc. appointed Roy Beveridge, M.D., senior vice president and CMO, effective June 17. Beveridge is CMO for McKesson Specialty Health.

Content questions or suggestions should be directed to BJ Taylor, editor of AIS's HEALTH BUSINESS DAILY, at bjtaylor@aishealth.com. If you are interested in sponsoring AIS's HEALTH BUSINESS DAILY, please contact Bailey Sterrett at bsterrett@aishealth.com.

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this e-mail to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at http://www.magnetmail.net/actions/ atlantic_subscription.cfm, where you can also sign up for AIS's Government News of the Week and Spotlight on Health Insurers. Copyright © 2013 Atlantic Information Services, Inc. (AIS). All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to rbiehl@aishealth.com.

Visit www.AISHealth.com
With archives of AIS's Health Business Daily, features like the News Archives, AIS Blogs and more! (Free registration required)